Page last updated: 2024-11-05

benzenediazonium

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

benzenediazonium: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

benzenediazonium : The aromatic diazonium ion formed from diazotisation of aniline. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID9718
CHEBI ID64466
SCHEMBL ID37140
MeSH IDM0107948

Synonyms (19)

Synonym
inchi=1/c6h5n2/c7-8-6-4-2-1-3-5-6/h1-5h/q+
benzenediazonium
benzenediazonium ion
C20284
2684-02-8
unii-2h8tus6r7a
2h8tus6r7a ,
phenyldiazonium
CHEBI:64466
benzenediazonium cation
benzeneazo
phenyl-diazonium
CIZVQWNPBGYCGK-UHFFFAOYSA-N
SCHEMBL37140
DTXSID9043772
phenyldiazonium ion
j83.281b ,
benzenediazonim
Q21099158

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
haptenAny substance capable of eliciting an immune response only when attached to a large carrier such as a protein. Examples include dinitrophenols; oligosaccharides; peptides; and heavy metals.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
aromatic diazonium ionA diazonium ion where one of the diazonium nitrogen atoms is connected to an aromatic group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (25)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (16.00)18.7374
1990's2 (8.00)18.2507
2000's11 (44.00)29.6817
2010's8 (32.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 72.83

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index72.83 (24.57)
Research Supply Index3.40 (2.92)
Research Growth Index4.98 (4.65)
Search Engine Demand Index120.02 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (72.83)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other29 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]